SOCIUM
SOCIUM is a drug discovery company focused on addressing unmet medical needs for patients with no or ineffective drug treatments. Leveraging its unique technology, the company utilizes an "Umbrella Drug Discovery" strategy to elucidate molecular mechanisms common to different diseases and explore the medicinal potential of a single drug across multiple conditions. Their core offerings include a drug repositioning platform based on proprietary technologies and the world's first phosphorylation analysis technology. This platform supports drug repurposing (indication hopping), phosphorylation analysis (activating pathway and kinase analysis), MOA clarification, target prediction, and stratification marker exploration. SOCIUM also engages in joint development of drug seeds discovered through these technologies, with a pipeline focused on areas like ALS treatment and rare diseases.
SOCIUM
SOCIUM is a drug discovery company focused on addressing unmet medical needs for patients with no or ineffective drug treatments. Leveraging its unique technology, the company utilizes an "Umbrella Drug Discovery" strategy to elucidate molecular mechanisms common to different diseases and explore the medicinal potential of a single drug across multiple conditions. Their core offerings include a drug repositioning platform based on proprietary technologies and the world's first phosphorylation analysis technology. This platform supports drug repurposing (indication hopping), phosphorylation analysis (activating pathway and kinase analysis), MOA clarification, target prediction, and stratification marker exploration. SOCIUM also engages in joint development of drug seeds discovered through these technologies, with a pipeline focused on areas like ALS treatment and rare diseases.